FIM
PGNX

Freedom Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Freedom Investment Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-56,745
Closed -$423K – 1189
2018
Q1 		$423K Buy
+56,745
New +$423K 0.02% 706